Cytokinetics (CYTK) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $85.50 +4.03%
EPS Growth %: -46.4%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: -46.4%
Financial Fact:
General and administrative: 7.22M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($0.23), $0.07 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $11.24 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades Cytokinetics (CYTK) to Buy
- Piper Sandler's Weekly Focus Idea: Principal Financial Group (PFG)
- KeyBanc Reiterates Overweight Rating on Worthington Steel Inc (WS)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
